In this Episode of the R&D Spotlight Series, our CEO and our translational medicine team discuss the key findings from our ESMO data and the impacts across the pre|CISION platform. One important finding is that tumors recruit fibroblasts during treatment, leading to an increased ability to release the payload. These data have a read across the platform and inform how pre|CISION works in the clinic.